![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Specgx Llc Webster Groves Us, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Buprenorphine hydrochloride, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2023-107 - Rev 00
This Chemical Type CEP, issued on August 24, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1181 associated with this CEP further emphasizes